Neurogene Inc.: 10-Q filed 2014-08-11
What Neurogene Inc. reported in its quarterly report filed 2014-08-11 (fiscal Q2 2014): 24 published measures, 73 facts as tagged in accession 0001193125-14-304867.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-11
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001193125-14-304867 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Neurogene Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 52,963,752 | USD | |
| At 2013-12-31 | 15,649,106 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,939,212 | USD | |
| At 2013-12-31 | 7,484,092 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 50,024,540 | USD | |
| At 2013-12-31 | -65,693,708 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 17,896,110 | USD | |
| At 2014-03-28 | 52,918,327 | USD | |
| At 2013-12-31 | 11,006,392 | USD | |
| At 2013-06-30 | 17,589,632 | USD | |
| At 2013-03-31 | 19,017,252 | USD | |
| At 2012-12-31 | 2,000,539 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | -5,424,759 | USD | 94 |
| 2014-01-01 to 2014-06-30 | -9,652,437 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -811,502 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,821,769 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 64,611 | USD | 94 |
| 2014-01-01 to 2014-06-30 | 69,074 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 2,537 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 7,233 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -75,040,984 | USD | |
| At 2013-12-31 | -65,693,708 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 116,869 | USD | |
| At 2013-12-31 | 75,465 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 214,822 | USD | 94 |
| 2014-01-01 to 2014-06-30 | 352,476 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 73,483 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 128,157 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 36,342,945 | USD | |
| At 2013-12-31 | 15,296,351 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 2,388 | USD | 94 |
| 2014-01-01 to 2014-06-30 | 456,196 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 1,769 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 3,603 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,846,116 | USD | |
| At 2013-12-31 | 2,620,105 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 5,632,393 | USD | 94 |
| 2014-01-01 to 2014-06-30 | 8,246,731 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 1,616,860 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 2,613,692 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 4,551,220 | USD | 94 |
| 2014-01-01 to 2014-06-30 | 6,430,734 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 1,247,103 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,820,070 | USD | 181 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 125,064,633 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 880 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 16,765 | USD | |
| At 2013-12-31 | 277,290 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 8,560 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | -5,424,759 | USD | 94 |
| 2014-01-01 to 2014-06-30 | -9,652,437 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -811,502 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,821,769 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | -5,423,879 | USD | 94 |
| 2014-01-01 to 2014-06-30 | -9,651,557 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -811,502 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,821,769 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | -5,424,759 | USD | 94 |
| 2014-01-01 to 2014-06-30 | -9,446,697 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -2,382,104 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -4,940,634 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 1,081,173 | USD | 94 |
| 2014-01-01 to 2014-06-30 | 1,815,997 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 369,757 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 793,622 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 71,938 | USD | 94 |
| 2014-01-01 to 2014-06-30 | 90,176 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 15,592 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 30,377 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-03-29 to 2014-06-30 | 207,634 | USD | 94 |
| 2014-01-01 to 2014-06-30 | -1,405,706 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 805,358 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 791,923 | USD | 181 |
Inspect the source
- Entity
- Neurogene Inc. / CIK 0001404644
- Captured
- 2026-09-19T11:18:01.681Z
- SEC response SHA-256
87b159cd5ceebdf479b494be364ba33f1e8263d79fdedbf945f7fab03349e1a8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001404644.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))